Document Detail


A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.
MedLine Citation:
PMID:  10365928     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Although it is important for physicians to have sufficient clinical data on which to base treatment decisions, little comparative data exist regarding newer treatment modalities for rosacea. OBJECTIVE: The goal of the study was to compare the efficacy and safety of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. Parameters of patient satisfaction to treatment were also assessed. METHODS: Forty patients with the clinical manifestation of symmetric facial rosacea were investigated in this single-center, double-blind, randomized, contralateral split-face comparison clinical trial. RESULTS: After 15 weeks of treatment, both azelaic acid and metronidazole induced significant, albeit equal reductions in the number of inflammatory lesions (pustules and papules). A significantly higher physician rating of global improvement was achieved with azelaic acid. Changes in the rosacea signs and symptoms of dryness, burning, telangiectasia, and itching were equal between treatments. A reduction in erythema tended toward significance with azelaic acid at week 15. A trace amount of stinging on application was noted with azelaic acid; however, such discomfort did not appear to concern patients because their overall impression of azelaic acid was superior to that of metronidazole. CONCLUSION: Azelaic acid 20% cream provides an effective and safe alternative to metronidazole 0.75% cream with the added benefit of increased patient satisfaction.
Authors:
S Maddin
Related Documents :
15966198 - Long-term response of primary biliary cirrhosis (stage i) to therapy with ursodeoxychol...
8300248 - The effect of fce 22891, a new oral penem, on faecal flora anaerobes and their fermenta...
6454598 - Effect of systemic erythromycin stearate on the inflammatory lesions and skin surface f...
20468638 - Condyloma accuminata: a new, more effective treatment.
17348678 - Statistical correlations between the in-mouth textural characteristics and the chemical...
12879748 - Individual and combined effect of (+/-)-alpha-hydrastine and (+/-)-beta-hydrastine on s...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  40     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-06-24     Completed Date:  1999-06-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  961-5     Citation Subset:  IM    
Affiliation:
Division of Dermatology, University of British Columbia, Vancouver, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Aged
Dermatologic Agents / administration & dosage*,  adverse effects
Dicarboxylic Acids / administration & dosage*,  adverse effects
Double-Blind Method
Humans
Metronidazole / administration & dosage*,  adverse effects
Middle Aged
Ointments
Patient Satisfaction
Rosacea / drug therapy*,  pathology
Chemical
Reg. No./Substance:
0/Dermatologic Agents; 0/Dicarboxylic Acids; 0/Ointments; 123-99-9/azelaic acid; 443-48-1/Metronidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Next Document:  Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 2...